About: Randomised double-blind comparison of lofexidine and methadone in the in-patient treatment of opiate withdrawal

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Randomised double-blind comparison of lofexidine and methadone in the in-patient treatment of opiate withdrawal Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 01 December 1996

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована в грудні 1996 (uk) im Dezember 1996 veröffentlichter wissenschaftlicher Artikel (de) artículu científicu espublizáu n'avientu de 1996 (ast) scientific article published on 01 December 1996 (en)
publication date	wds:Q59769137-CEB06901-A260-4D77-9CA0-99B66DF99A33
publication date	1996-12-01 00:00:00Z (xsd:dateTime)
cites work	wds:Q59769137-005A76E8-E00B-49C2-8A22-806F6EF455F4 wds:Q59769137-44E1F4FA-77E1-4793-A123-334598114504 wds:Q59769137-5FB5756C-5722-4B72-83B9-73645FC3B8A0 wds:Q59769137-689EDEA8-C94F-48A4-99EC-6864F3C64957 wds:Q59769137-8B37D913-D85E-4155-B724-5C128FD5FFB7 wds:Q59769137-BCB482EF-FBA7-4B57-8967-3E86BC6CF164 wds:Q59769137-C12B6FB8-D0D9-45C7-ACD5-FB033AF159B8
cites work	The development of a Short Opiate Withdrawal Scale (SOWS) Comparison of linear versus inverse exponential methadone reduction curves in the detoxification of opiate addicts Opiate withdrawal symptoms in response to 10-day and 21-day methadone withdrawal programmes The clinical use of clonidine in abrupt withdrawal from methadone. Effects on blood pressure and specific signs and symptoms Clonidine in morphine withdrawal. Differential effects on signs and symptoms Opiate detoxification with lofexidine The Drug Advisory Service of England and Wales-the first 2 years
author name string	wds:Q59769137-50AE4330-C44E-4220-929E-6B16F20B07A6 wds:Q59769137-8AE6E2E3-346F-4982-9564-5F48DE8A0DB1
author name string	M Gossop J Bearn
rdfs:label	Randomised double-blind comparison of lofexidine and methadone in the in-patient treatment of opiate withdrawal (en) Randomised double-blind comparison of lofexidine and methadone in the in-patient treatment of opiate withdrawal (nl)
skos:prefLabel	Randomised double-blind comparison of lofexidine and methadone in the in-patient treatment of opiate withdrawal (en) Randomised double-blind comparison of lofexidine and methadone in the in-patient treatment of opiate withdrawal (nl)
name	Randomised double-blind comparison of lofexidine and methadone in the in-patient treatment of opiate withdrawal (en) Randomised double-blind comparison of lofexidine and methadone in the in-patient treatment of opiate withdrawal (nl)
author	wds:Q59769137-C9C8E0FE-F016-4DF6-8FC9-6F90D58EE0D8
author	John Strang
title	wds:Q59769137-1944875B-8790-4C8B-BD5E-4DD1FFA57DDE
title	Randomised double-blind comparison of lofexidine and methadone in the in-patient treatment of opiate withdrawal (en)
page(s)	wds:Q59769137-4C304DC4-A541-4D19-80BD-C536BE1C743D
page(s)	87-91
instance of	wds:Q59769137-BF3CE6B2-44E0-4665-9661-E3B7A1393415
instance of	scholarly article
PubMed ID	wds:Q59769137-E021C60E-A39E-44CD-BB1A-9994F4584E1D
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/8957147
PubMed ID	8957147
published in	wds:Q59769137-1A930FEB-387A-451F-A511-195B40A480DF
published in	Drug and Alcohol Dependence
issue	wds:Q59769137-136216B5-E9BF-4B7B-80B7-FC83483B68A0
volume	wds:Q59769137-F3C399EF-03D6-468E-A3F2-21906921FF7B
issue	1-2
volume	43
DOI	wds:Q59769137-5D7CA0D5-9F12-4C6F-AEC2-9CBFE8BD1422
DOI	http://dx.doi.org/10.1016/S0376-8716(96)01289-6
DOI	10.1016/S0376-8716(96)01289-6
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q59769137
is cites work of	Predictors for completing an inpatient detoxification program among intravenous heroin users, methadone substituted and codeine substituted patients Two methods of community detoxification from opiates: an open-label comparison of lofexidine and buprenorphine Methadone at tapered doses for the management of opioid withdrawal Prison based detoxification for opioid dependence: a randomised double blind controlled trial of lofexidine and methadone Double-blind randomised controlled trial of lofexidine versus clonidine in the treatment of heroin withdrawal Randomised double-blind comparison of lofexidine and clonidine in the out-patient treatment of opiate withdrawal Effects of THC and lofexidine in a human laboratory model of marijuana withdrawal and relapse Guanfacine enhances inhibitory control and attentional shifting in early abstinent cocaine-dependent individuals The role of guanfacine as a therapeutic agent to address stress-related pathophysiology in cocaine-dependent individuals Methadone at tapered doses for the management of opioid withdrawal Alpha 2 -adrenergic agonists for the management of opioid withdrawal Methadone at tapered doses for the management of opioid withdrawal Accelerated lofexidine treatment regimen compared with conventional lofexidine and methadone treatment for in-patient opiate detoxification. Rapid opiate detoxication in outpatient treatment: relationship with naltrexone compliance. Alpha2-adrenergic agonists for the management of opioid withdrawal Treatment interventions-looking towards the millennium Alpha2-adrenergic agonists for the management of opioid withdrawal Alpha2 adrenergic agonists for the management of opioid withdrawal A Phase 3 placebo-controlled, double-blind, multi-site trial of the alpha-2-adrenergic agonist, lofexidine, for opioid withdrawal Major disruptions of sleep during treatment of the opiate withdrawal syndrome: differences between methadone and lofexidine detoxification treatments. Pharmacological therapies for management of opium withdrawal Is it prime time for alpha2-adrenocepter agonists in the treatment of withdrawal syndromes? Lofexidine versus clonidine in rapid opiate detoxification Naltrexone and lofexidine combination treatment compared with conventional lofexidine treatment for in-patient opiate detoxification Lofexidine in opiate withdrawal: a safety and usage survey Clinical Efficacy and Safety Profile of Lofexidine Hydrochloride in Treating Opioid Withdrawal Symptoms: A Review of Literature Comparison of the efficacy of buprenorphine and clonidine in detoxification of opioid-dependents Sulphatoxymelatonin excretion during opiate withdrawal: a preliminary study Evidence-based addiction medicine: the use of lofexidine for opioid detoxification.
is cites work of	wds:Q35608560-A9F75D81-5095-497A-BBEB-EDC9FCB90B47 wds:Q24200729-56D2C22C-B8ED-48C4-BD2E-CAB42BC8FB3F wds:Q33700819-E6B6580D-153B-478B-820E-9721469E43B9 wds:Q42546661-1F796897-D233-4594-8149-13B36906BEB4 wds:Q24185795-9B4C63E1-E8AC-49B6-ADC8-99F0F990C288 wds:Q24245988-E4B01CE2-D4B5-4185-B8D8-C1BA168A8F3A wds:Q33598487-F2B63C15-53B2-4321-87CE-607D1C675DB8 wds:Q82690995-42337679-9153-4D22-8003-2BA80827AF79 wds:Q37036723-E8A49950-58C2-4FDE-A71F-843747966303 wds:Q24246574-349C4B04-75DE-4F8D-833F-22CCED6E43CB wds:Q36024183-030313B8-A3A7-4FD5-8F13-726A1C45F2DA wds:Q42541323-BE66A376-41EC-4D3E-8E02-97B49B41A35D wds:Q44049012-E2C5D777-DA17-4F4B-8215-D84BF266DB34 wds:Q44439966-F4387114-7805-4457-B0EA-7CD9713C6D33 wds:Q92557570-DBEA9BCB-2048-4FE4-8F4E-16BF66341A22 wds:Q24241305-DF835A88-8DE9-4906-853F-50583EA959A6 wds:Q24197769-51A92B05-D58B-4B7D-BBD7-A2153C5DB9C4 wds:Q43803507-A0891C2F-9B33-40AF-A87D-CC2B4180658E

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 172 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software